US STOCKS-S&P 500 set to dip after vaccine news rally

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Market cools after huge Monday rally
* Pandemic tech winners retreat
* Financials, energy and travel stocks edge higher
* Futures: Dow up 0.7%, S&P down 0.1%, Nasdaq down 1.5%

(Adds comment, details; updates prices)
By Medha Singh and Shivani Kumaresan
Nov 10 (Reuters) - The S&P 500 was set to open lower on
Tuesday as excitement over signs of a first successful
late-stage COVID-19 vaccine trial faded, while investors
continued to pull money out of the big tech companies that have
benefitted most from the pandemic.
Technology-focused stocks, which have benefited from this
year's work-from-home shift and powered Wall Street to new
heights, were the odd ones out in a broad rally on Monday, and
futures for the tech-heavy Nasdaq 100 NQcv1 were again down
1.5% in early trade.
Netflix Inc NFLX.O , Amazon.com Inc AMZN.O , Facebook Inc
FB.O , and Apple Inc AAPL.O fell between 1.8% and 2.3% as
investors rotated into sectors that are expected to benefit from
a full reopening of the economy such as travel, energy and
financials, although the latter moves were muted compared to the
previous day.
"The rotation could be different this time because.. it is
predicated on the fact that we have evidence to say things will
get better," said Art Hogan, chief market strategist at National
Securities in New York.
The main U.S. indexes hit new peaks on Monday as data from
Pfizer's late-stage COVID-19 vaccine trial spurred bets of a
swift economic recovery next year. Democrat Joe Biden's
projected victory in the U.S. presidential election also added
to the market cheer.
Biden hailed the progress on the vaccine, but urged caution
saying it would be "many more months" before widespread
vaccination is available. Meanwhile, daily new U.S. cases topped
100,000 for the sixth straight day. U.S. regulators on Monday also authorized emergency use of
the first experimental antibody drug for COVID-19 developed by
Eli Lilly & Co LLY.N , pushing its shares up by 3.4%.
At 08:23 a.m. ET, Dow futures were up 0.7%, led by a 4% jump
for Amgen Inc AMGN.O after its asthma drug, being developed in
collaboration with AstraZeneca AZN.L , met the main goal of a
late-stage study.
S&P 500 E-minis EScv1 were down 0.14%.
Shares of big U.S. banks, which are sensitive to the broader
economic outlook, edged higher while cruise line operators and
airlines battered by travel restrictions gained between 1% and
4.3%. CCL.N RCL.N DAL.N UAL.O
One big set-piece on Tuesday will by an Apple event,
expected to unveil new Mac computers using its own in-house
processor chips.